Opioid Tolerance Treatment Market by Drug, Type of Opioid Tolerance and Forecast to 2027

1
Opioid Tolerance Treatment Market
Opioid Tolerance Treatment Market Segmentation
by Drug - NMDA Antagonists (Ketamine,
Dextromethorphan, Others), Alpha2-Adrenoceptor
Agonists (Clonidine, Tizanidine, and Others)
Type of Opioid Tolerance - Innate Tolerance,
Acquired Tolerance Route of Administration -
Enteral, Parenteral End use - Hospitals and
Ambulatory Surgery Centers, Rehabilitation
Centers, Forecast, 2019 - 2027
2019 Transparency Market Research, All Rights
Reserved
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Opioid Tolerance Treatment Market
Chapter 4 Market Overview
Chapter 5 Global Opioid Tolerance Treatment Market Analysis and Forecasts, by Drug 
Chapter 6 Global Opioid Tolerance Treatment Market Analysis and Forecasts, by Type of Opioid Tolerance
Chapter 7 Global Opioid Tolerance Treatment Market Analysis and Forecasts, by Route of Administration
Chapter 8 Global Opioid Tolerance Treatment Market Analysis and Forecasts, by End-user
Chapter 9 Global Opioid Tolerance Treatment Market Analysis and Forecasts, by Region
Chapter 10 North America Opioid Tolerance Treatment Market Analysis and Forecast
Chapter 11 Europe Opioid Tolerance Treatment Market Analysis and Forecast
Chapter 12 Asia Pacific Opioid Tolerance Treatment Market Analysis and Forecast
Chapter 13 Latin America Opioid Tolerance Treatment Market Analysis and Forecast
Chapter 14 Middle East Africa Opioid Tolerance Treatment Market Analysis and Forecast
Chapter 15 Competition Landscape
2019 Transparency Market Research, All Rights
Reserved
3

Opioid Tolerance Treatment Market - Snapshot

• Opioids are effective analgesics prescribed to
  people with chronic cancer and severe pain.
• Opioid tolerant patients can be treated with
  other treatment options for opioid tolerance such
  as NMDA antagonists and alpha2-adrenoceptor
  agonists.
• The global opioid tolerance treatment market is
  anticipated to expand at a CAGR of around 3.5
  from 2019 to 2027.

2019 Transparency Market Research, All Rights
Reserved
4
(No Transcript)
5
Report Highlights

• The opioid tolerance treatment market is
  expanding at a significant pace due to rise in
  consumption of opioids for medical non-medical
  purposes.
• The alpha2-adrenoceptor agonists segment
  dominates the global opioid tolerance treatment
  market in terms of value and is expected to
  continue this trend during the forecast period.
• Additionally, ongoing clinical trials, various
  researches going on for opioid tolerant treatment
  by different research institutes companies.

Request For Sample
2019 Transparency Market Research, All Rights
Reserved
6
Continue..

• Acquired Tolerance Segment to Dominate the Type
  Category
• In type, the acquired tolerance segment is
  projected to lead the global opioid tolerance
  treatment market. It shall account for 74 of
  total market.
• In terms of geography, the global opioid
  tolerance treatment market is dominated by the
  North American region.
• Key players operating in the global opioid
  tolerance treatment market include- Boehringer
  Ingelheim International GmbH, GlaxoSmithKline
  plc., and Teva Pharmaceutical Industries Ltd.

Request For Brochure
2019 Transparency Market Research, All Rights
Reserved
7
Contact
To know more about us, please visit our website
www.transparencymarketresearch.com For sales
queries or new topics email us on
sales_at_transparencymarketresearch.com
Thank You
2019 Transparency Market Research, All Rights
Reserved